A Smart Device System (Wearable technology band) to Identify New Phenotypical Characteristics in Parkinson‘s disease patients
Objective: To develop methods for analyzes and monitor of gait data via smart device system and identify new phenotypical characteristics in PD patients. Background: Parkinson's…The Impact of Progressive Supranuclear Palsy (PSP) Disease Severity on Caregivers
Objective: To quantify the impact of varying severity levels on caregivers’ burden and health-related quality of life (HRQoL). Background: PSP is a progressive disease. Patients…The Effectiveness of Rehabilitation Using Honda Walking Assist in Parkinson’s Disease Patients; The Gait Analysis by a Markerless Motion Capture System
Objective: We verified the usefulness of an automatic gait and posture analyzer for estimation of rehabilitation using Honda Walking Assist (HWA). Background: The abnormal posture…Immediate effect of the virtual and augmented reality and neurofunctional physiotherapy on postural control and cognition in patients with Parkinson’s disease: a randomized clinical trial
Objective: To evaluate the immediate effect of augmented reality (AR), virtual reality (VR) and neurofunctional physiotherapy (NP) in postural control and cognition of patients with…Factors Influencing Decision-Making About End of Life Care in Patients With Parkinson’s Disease and Their Family Members
Objective: The aim of the research was to determine factors influencing decision-making about end of life care in patients with Parkinson´s disease (PD) and their…Differential Gait Progression in idiopathic Parkinson’s disease with and without freezing of gait
Objective: To develop a predictive algorithm for freezing of gait (FOG) in Parkinson’s disease (PD) through longitudinal objective gait assessment. Background: The presence of FOG…Pilot testing of the Integrated Parkinson’s Disease Care Network: feasibility, efficacy outcomes and cost description analysis
Objective: To evaluate a new model of care delivery in PD, the Integrated Parkinson’s disease Care Network (IPCN), in terms of implementation, health-related outcomes, patient/care…Inhibition of mitochondrial complexes induces unique transcriptomic and epigenetic profiles: implications to neurodegeneration induced movement disorders
Objective: To compare the neurotoxicological hallmarks induced by inhibitors of mitochondrial complex I (CI- 1- methyl-4- phenylpyridinium; MPP+), complex II (CII- 3- nitropropionic acid; 3-…Population Exposure-Response Models of Apomorphine Sublingual Film in Healthy Subjects and Patients With Parkinson’s Disease and “OFF” Episodes
Objective: Exposure-response models were developed to characterize the relationship between apomorphine exposure and (1) efficacy using Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease…A possible case of prodromal DLB with prominent hallucinations, autonomic dysfunction, and REM behavior disorder but absence of cognitive impairment
Objective: Dementia with Lewy bodies (DLB) is the second most common cause of neurodegenerative dementia, after Alzheimer’s disease (AD). While mild cognitive impairment (MCI) is…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 217
- Next Page »